Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters ; day:14 ; month:7 ; year:2020 ; pages:1-7
European journal of clinical pharmacology ; (14.7.2020), 1-7
- Urheber
-
Katsube, Takayuki
Inoue, Yuji
Fukuhara, Takahiro
Kano, Takeshi
Wajima, Toshihiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-020-02960-7
- URN
-
urn:nbn:de:101:1-2020091020111730549309
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Katsube, Takayuki
- Inoue, Yuji
- Fukuhara, Takahiro
- Kano, Takeshi
- Wajima, Toshihiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction